AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

CYduct Diagnostics, Inc.

$1 +$0.80 (+392.37%)
OTC · 14 Sep 2026 20:00 UTC
Previous Close
$1
Day Range
$1 - $1
Year Range
$0.2$2.9
Market Cap
5.24M
AVG Volume
1.79K
Trailing/Forward PE
-14.97/-
PEG ratio
-1.05
Dividend Yield
-
Next Earnings Date
-
Primary Exchange
Other OTCUS
Revenue (USD) · TTM
025K50K75K100K23 Q223 Q323 Q424 Q124 Q224 Q324 Q425 Q125 Q225 Q3
CYDX Revenue (USD) · TTM by quarter
PeriodRevenue (USD) · TTM
25 Q365.69K
25 Q259.27K
25 Q169.03K
24 Q470.69K
24 Q372.58K
24 Q276.81K
24 Q170.05K
23 Q484.48K
23 Q388.7K
23 Q284.52K
Net Income (USD) · TTM
-600K-400K-200K023 Q223 Q323 Q424 Q124 Q224 Q324 Q425 Q125 Q225 Q3
CYDX Net Income (USD) · TTM by quarter
PeriodNet Income (USD) · TTM
25 Q3-349.6K
25 Q2-383.13K
25 Q1-387.98K
24 Q4-409.84K
24 Q3-404.18K
24 Q2-409.97K
24 Q1-427.49K
23 Q4-416.13K
23 Q3-444.33K
23 Q2-457.13K
Operating Income (USD) · TTM
-600K-400K-200K023 Q223 Q323 Q424 Q124 Q224 Q324 Q425 Q125 Q225 Q3
CYDX Operating Income (USD) · TTM by quarter
PeriodOperating Income (USD) · TTM
25 Q3-301.45K
25 Q2-335.07K
25 Q1-340.06K
24 Q4-363.22K
24 Q3-355.51K
24 Q2-364.33K
24 Q1-385.73K
23 Q4-376.99K
23 Q3-408.24K
23 Q2-423.14K
EBITDA (USD) · TTM
-400K-300K-200K-100K023 Q223 Q323 Q424 Q124 Q224 Q324 Q425 Q125 Q225 Q3
CYDX EBITDA (USD) · TTM by quarter
PeriodEBITDA (USD) · TTM
25 Q3-297.68K
25 Q2-331.3K
25 Q1-336.29K
24 Q4-359.44K
24 Q3-355.51K
24 Q2-364.33K
24 Q1-385.73K
23 Q4-377K
23 Q3-353.36K
23 Q2-368.26K
Cash Flows (USD) · TTM
-300K-200K-100K0100K23 Q223 Q323 Q424 Q124 Q224 Q324 Q425 Q125 Q225 Q3
CYDX Cash Flows (USD) · TTM by quarter
PeriodCash Flows (USD) · TTM
25 Q310.29K
25 Q2-18.68K
25 Q1-45.5K
24 Q4-71.98K
24 Q3-106.74K
24 Q2-129.71K
24 Q1-155.78K
23 Q4-174.83K
23 Q3-212.44K
23 Q2-244.58K
EPS (USD) · TTM
-0.1-0.08-0.05-0.03-023 Q223 Q323 Q424 Q124 Q224 Q324 Q425 Q125 Q225 Q3
CYDX EPS (USD) · TTM by quarter
PeriodEPS (USD) · TTM
25 Q3-0.07
25 Q2-0.07
25 Q1-0.07
24 Q4-0.08
24 Q3-0.08
24 Q2-0.08
24 Q1-0.08
23 Q4-0.08
23 Q3-0.09
23 Q2-0.09
Expenses (USD) · TTM
0200K400K600KSG&ACapex23 Q223 Q323 Q424 Q124 Q224 Q324 Q425 Q125 Q225 Q3
CYDX Expenses (USD) · TTM by quarter
PeriodExpenses (USD) · TTM
25 Q3337.53K
25 Q2370.35K
25 Q1381.98K
24 Q4406.24K
24 Q3402.12K
24 Q2415.7K
24 Q1431.69K
23 Q4433K
23 Q3471.21K
23 Q2482.25K
Free Cash Flow Yield
-30%-20%-10%0%10%med -6.76%Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
CYDX Free Cash Flow Yield by quarter
PeriodFree Cash Flow Yield
Sep 260.2%
Sep 260.16%
Aug 260.17%
Aug 260.17%
Aug 260.09%
Aug 260.09%
Jul 260.09%
Jul 260.07%
Jul 260.07%
Jul 260.13%
Jul 260.47%
Jun 26-0.85%
Jun 26-0.88%
Jun 26-0.88%
Jun 26-0.88%
May 26-0.88%
May 26-0.88%
May 26-0.58%
May 26-0.58%
May 26-0.58%
Apr 26-0.58%
Apr 26-0.58%
Apr 26-0.58%
Apr 26-0.57%
Mar 26-1.39%
Mar 26-1.23%
Mar 26-1.23%
Mar 26-1.17%
Feb 26-1.03%
Feb 26-0.89%
Feb 26-0.89%
Feb 26-1.4%
Jan 26-1.09%
Jan 26-0.32%
Jan 26-0.32%
Jan 26-4.27%
Jan 26-4.27%
Dec 25-6.76%
Dec 25-6.76%
Dec 25-6.76%
Dec 25-6.76%
Nov 25-6.76%
Nov 25-6.76%
Nov 25-6.76%
Nov 25-6.76%
Oct 25-6.76%
Oct 25-6.83%
Oct 25-3.14%
Oct 25-3.14%
Oct 25-5.09%
Sep 25-8.67%
Sep 25-8.08%
Sep 25-8.08%
Sep 25-8.08%
Aug 25-8.08%
Aug 25-8.08%
Aug 25-8.08%
Aug 25-8.08%
Aug 25-8.08%
Jul 25-8.08%
Jul 25-8.08%
Jul 25-8.08%
Jul 25-8.08%
Jun 25-9.82%
Jun 25-9.82%
Jun 25-4.97%
Jun 25-4.97%
May 25-5.07%
May 25-12.19%
May 25-12.19%
May 25-12.19%
May 25-12.19%
Apr 25-12.19%
Apr 25-12.25%
Apr 25-12.25%
Apr 25-12.25%
Mar 25-14.71%
Mar 25-14.86%
Mar 25-14.86%
Mar 25-14.86%
Feb 25-14.86%
Feb 25-14.86%
Feb 25-14.86%
Feb 25-19.54%
Jan 25-19.54%
Jan 25-19.54%
Jan 25-19.54%
Jan 25-19.54%
Jan 25-19.54%
Dec 24-21.93%
Dec 24-21.95%
Dec 24-21.95%
Dec 24-22.08%
Nov 24-22.08%
Nov 24-22.08%
Nov 24-22.08%
Nov 24-22.08%
Nov 24-22.08%
Oct 24-22.08%
Oct 24-23.79%
Price to Sales
0100200300med 18.2Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
CYDX Price to Sales by quarter
PeriodPrice to Sales
Sep 2679.78
Sep 2698.93
Aug 2693.34
Aug 2693.34
Aug 26165.94
Aug 26165.94
Jul 26165.94
Jul 26215.41
Jul 26215.41
Jul 26118.08
Jul 2633.51
Jun 2637.13
Jun 2635.63
Jun 2635.63
Jun 2635.63
May 2635.63
May 2635.63
May 2653.93
May 2653.93
May 2653.93
Apr 2653.93
Apr 2653.93
Apr 2653.93
Apr 2655.35
Mar 2647.53
Mar 2653.74
Mar 2653.74
Mar 2656.53
Feb 2664.12
Feb 2674.41
Feb 2674.41
Feb 2647.08
Jan 2660.74
Jan 26204.98
Jan 26204.98
Jan 2615.42
Jan 2615.42
Dec 2515.06
Dec 2515.06
Dec 2515.06
Dec 2515.06
Nov 2515.06
Nov 2515.06
Nov 2515.06
Nov 2515.06
Oct 2515.06
Oct 2514.91
Oct 2532.47
Oct 2532.47
Oct 2520.02
Sep 2516.96
Sep 2518.2
Sep 2518.2
Sep 2518.2
Aug 2518.2
Aug 2518.2
Aug 2518.2
Aug 2518.2
Aug 2518.2
Jul 2518.2
Jul 2518.2
Jul 2518.2
Jul 2518.2
Jun 2517.2
Jun 2517.2
Jun 2533.98
Jun 2533.98
May 2533.3
May 2513.86
May 2513.86
May 2513.86
May 2513.86
Apr 2513.86
Apr 2513.79
Apr 2513.79
Apr 2513.79
Mar 2515.12
Mar 2514.96
Mar 2514.96
Mar 2514.96
Feb 2514.96
Feb 2514.96
Feb 2514.96
Feb 2511.38
Jan 2511.38
Jan 2511.38
Jan 2511.38
Jan 2511.38
Jan 2511.38
Dec 249.44
Dec 249.43
Dec 249.43
Dec 249.37
Nov 249.37
Nov 249.37
Nov 249.37
Nov 249.37
Nov 249.37
Oct 249.37
Oct 248.7
Price/Operating Cashflow
050010001500med 753.42Jul 26Jul 26Jul 26Aug 26Aug 26Sep 26
CYDX Price/Operating Cashflow by quarter
PeriodPrice/Operating Cashflow
Sep 26509.07
Sep 26631.24
Aug 26595.61
Aug 26595.61
Aug 261058.86
Aug 261058.86
Jul 261058.86
Jul 261374.48
Jul 261374.48
Jul 26753.42
Jul 26213.81
CYduct Diagnostics, Inc.
CYDX
Stockpicker

Video analysis: CYDX

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.